Clinical Trial Update: Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study [Phase 2]

View source ↗

Summary

A randomized Phase 2 trial evaluated the efficacy and safety of anakinra for refractory adult-onset Still's disease. The study status indicates completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adult-onset Still Disease

Drugs mentioned

• Anakinra (Kineret) (Anakinra)

Snippet

Sponsor: University of Helsinki | Conditions: Adult-Onset Still's Disease | Phase 2 | Status: COMPLETED